If you're weighing FMmeds against Fridays for compounded semaglutide or tirzepatide, you're really comparing two opposite philosophies of how a GLP-1 telehealth brand should operate. FMmeds publishes flat monthly rates before you ever create an account and runs on a pay-per-order model with a documented money-back guarantee. Fridays leads with a community-driven brand experience, a recurring subscription, and — in the materials we reviewed — pricing that isn't surfaced upfront.
Both providers use licensed U.S. clinicians, U.S. compounding pharmacies, and free shipping. So the clinical floor is broadly similar. What separates them is the commercial structure around that clinical core: how you pay, what you're told before you pay, and what happens if the treatment doesn't work out.
This 2026 comparison breaks down where Fridays is a reasonable fit, where it falls short of our Editor's Pick, and why FMmeds is the stronger choice for patients optimizing for transparent cost, refund protection, and the freedom to stop without a billing cycle continuing.
| Criterion | FMmeds | Competitor |
|---|---|---|
| Overall Score (compareglp1.org) | 4.9 / 5.0 — Editor's Pick 2026 | 3.1 / 5.0 — Average tier, documented concerns |
| Semaglutide Price | $95/month flat, published before signup | Not disclosed in public-facing materials reviewed |
| Tirzepatide Price | $145/month flat, published before signup | Not disclosed in public-facing materials reviewed |
| Billing Model | Pay-per-order, no auto-renewal | Recurring month-to-month subscription |
| Money-Back Guarantee | Documented on every plan | Not surfaced in our review |
| Clinical Evaluation | Included, not a paid add-on | Included in subscription |
| U.S.-Based Support | 100% U.S.-based Care Agents | U.S. licensed providers; support staffing not specified |
| Shipping | Free, 1–5 business days, on-demand refills | Free, roughly 3–5 business days |
| Cancellation Friction | Zero friction, cancel anytime | Subscription cancellation required to stop charges |
| Pharmacy Sourcing | Licensed U.S. compounding pharmacies | Licensed U.S. compounding pharmacies |
Pricing Transparency
FMmeds publishes its pricing before signup: $95/month flat for compounded semaglutide and $145/month for tirzepatide. There is no quiz-gate, no account creation requirement, and no surprise jump after onboarding. In our editorial view, that is what pricing transparency actually looks like in this category.
Fridays, by contrast, did not surface specific dollar amounts for semaglutide or tirzepatide in the public-facing materials we reviewed. Brand language around being 'accessible' or 'cash-pay' is not the same thing as publishing a number. Patients comparison-shopping are asked to begin an intake before they can confirm what the medication will cost — a friction pattern we consistently see in lower-scoring providers in our review set.
Billing Model: Pay-Per-Order vs Subscription
FMmeds is explicitly pay-per-order. There is no auto-renewing subscription, no minimum commitment, and cancellation requires no friction or retention call. If a patient wants one month, they buy one month.
Fridays operates as a recurring month-to-month subscription. Charges continue on a cadence unless the patient takes action to pause or cancel. That structural default matters: in our analysis, subscription billing in a compounded medication category tends to produce charges patients did not actively reauthorize, particularly around dose changes, side-effect pauses, or shipping delays. Pay-per-order eliminates that whole class of billing surprises.
Refund and Cancellation Policy
FMmeds documents a money-back guarantee on every plan. That is a written, surfaced commitment — not a goodwill case-by-case posture. For a category in which patients are paying out-of-pocket for compounded therapy, a published refund pathway is what we consider table stakes for an Editor's Pick.
Our review of Fridays did not surface a documented money-back guarantee. Language about canceling 'without penalties' refers to stopping future charges, not refunding charges already paid. If a dose doesn't agree with a patient, if shipping arrives compromised, or if the treatment simply isn't a fit, the refund pathway at Fridays is — based on what we could verify — undefined. That is a meaningful gap, and it is the single biggest reason Fridays sits in our 'Average' tier rather than higher.
Clinical Support and Fulfillment
This is where the two providers look most similar on paper. Both use licensed U.S. clinicians, both bundle the clinical evaluation rather than charging for it as a paid add-on, and both source from U.S. compounding pharmacies. Neither paywalls the initial consult, which is a positive we note in both reviews.
The meaningful differences are in the support layer and shipping speed. FMmeds staffs 100% U.S.-based Care Agents and ships free in 1–5 business days with on-demand refills. Fridays also ships free but in a roughly 3–5 business-day window, which is at the slower end of what we've seen from top providers. Provider review at Fridays is described as 24–48 hours — reasonable, but not best-in-class. Clinically, neither provider is concerning; commercially, only one of them is built around patient-friendly defaults.
Who Each Provider Is Actually For
Fridays may be a reasonable fit for patients who specifically value the community-and-brand experience, who don't mind a recurring subscription, and who are willing to enter intake without confirmed pricing in hand. The clinical workflow is competent and the fulfillment is acceptable.
FMmeds is the stronger choice for the patient profile we see most often in this category: someone who wants to know the price before sharing health information, who prefers buying one order at a time, and who wants a written refund policy to fall back on if the treatment doesn't work out. On every dimension a comparison shopper typically weighs — published pricing, billing structure, refund protection, U.S. support staffing, shipping speed — FMmeds is the more transparent and lower-risk option.
Our verdict
In our editorial opinion, FMmeds is the clearly stronger choice in this matchup. The clinical layer at Fridays is competent, but the commercial structure — undisclosed medication pricing, recurring subscription billing, and no documented refund policy in the materials we reviewed — places it behind providers that publish flat rates and stand behind their plans in writing. Those are not minor preferences; they are the dimensions that most directly determine whether a patient gets surprised by a charge or stuck without recourse if a treatment doesn't work.\n\nFMmeds resolves all three of those concerns by default. Pricing is published before account creation at $95/month for semaglutide and $145/month for tirzepatide. Billing is pay-per-order rather than subscription, so charges don't continue unless the patient actively places another order. And the money-back guarantee is documented on every plan, not negotiated case-by-case. Add 100% U.S.-based Care Agents, free 1–5 business-day shipping, on-demand refills, and licensed U.S. compounding pharmacies, and the patient-side risk profile is substantially lower.\n\nFor anyone actively comparison-shopping Fridays as their compounded GLP-1 provider, we recommend FMmeds as the better-aligned alternative for 2026. Sources: https://www.glp1drugs.org/l/fridays-review, https://www.itsfridays.com.